Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2266 |
|
| Actual shortage: | 50 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2197 (97%) | |
Discontinuation Reports |
124 |
|
| To be discontinued: | 4 (3%) | |
| Discontinued: | 118 (95%) | |
| Reversed: | 2 (2%) | |
Late reports |
451 (19%) |
|
Overdue reports |
11 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2022-02-08 | 2022-03-15 | 154523 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2022-08-18 | 2022-11-29 | 167366 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2022-08-18 | 2022-11-29 | 167369 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-03-03 | 2023-04-05 | 186160 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-09-11 | 2023-10-11 | 204118 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-11-13 | 2023-12-05 | 210061 |
| HALOPERIDOL INJ 5MG/ML USP | 5MG | LIQUID | Resolved | 2022-10-04 | 2022-10-20 | 171063 |
| HALOPERIDOL INJ 5MG/ML USP | 5MG | LIQUID | Resolved | 2022-11-16 | 2022-11-17 | 174901 |
| HALOPERIDOL INJ 5MG/ML USP | 5MG | LIQUID | Resolved | 2022-12-12 | 2023-02-01 | 177931 |
| HALOPERIDOL INJ 5MG/ML USP | 5MG | LIQUID | Resolved | 2023-03-03 | 2023-03-14 | 186163 |
| HALOPERIDOL LA | 100MG | LIQUID | Resolved | 2018-07-30 | 2018-12-17 | 56881 |
| HALOPERIDOL LA | 100MG | LIQUID | Resolved | 2018-09-30 | 2018-10-04 | 62723 |
| HALOPERIDOL LA | 100MG | LIQUID | Resolved | 2021-06-14 | 2021-08-03 | 140850 |
| HALOPERIDOL LA | 100MG | LIQUID | Resolved | 2022-04-20 | 2022-09-02 | 159048 |
| HALOPERIDOL LA | 100MG | LIQUID | Resolved | 2022-11-16 | 2022-12-29 | 174904 |
| HALOPERIDOL LA | 100MG | LIQUID | Resolved | 2023-12-19 | 2024-01-17 | 213813 |
| HALOPERIDOL LA | 100MG | LIQUID | Resolved | 2025-08-15 | 2025-09-13 | 265318 |
| HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | 1000UNIT | SOLUTION | Resolved | 2021-01-18 | 2021-02-01 | 131827 |
| HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | 1000UNIT | SOLUTION | Resolved | 2021-07-05 | 2022-08-18 | 141775 |
| HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | 1000UNIT | SOLUTION | Resolved | 2022-09-01 | 2022-09-28 | 168474 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OLANZAPINE FOR INJECTION | 10MG | POWDER FOR SOLUTION | Discontinued | 2020-06-22 | 2020-06-22 | 118553 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2024-10-29 | 2024-10-29 | 241520 |
| POLYTOPIC | 500UNIT 10000UNIT | OINTMENT | Discontinued | 2020-04-01 | 2020-04-01 | 110309 |
| RANITIDINE INJECTION USP | 50MG | SOLUTION | Discontinued | 2020-11-02 | 2020-11-03 | 127684 |
| RANITIDINE INJECTION USP | 50MG | SOLUTION | Discontinued | 2020-11-02 | 2020-11-03 | 127687 |
| SANDOZ ALENDRONATE | 10MG | TABLET | Discontinued | 2019-11-19 | 2019-11-19 | 99259 |
| SANDOZ ALENDRONATE | 70MG | TABLET | Discontinued | 2025-01-06 | 2025-01-06 | 246849 |
| SANDOZ AMBRISENTAN TABLETS | 5MG | TABLET | Discontinued | 2025-06-30 | 2025-06-30 | 261365 |
| SANDOZ AMBRISENTAN TABLETS | 10MG | TABLET | Discontinued | 2025-07-02 | 2025-07-03 | 261512 |
| SANDOZ AMPHETAMINE XR | 10MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2025-05-15 | 2025-11-18 | 257368 |
| SANDOZ AMPHETAMINE XR | 5MG | CAPSULE (EXTENDED RELEASE) | To be discontinued | 2025-05-15 | 2025-05-15 | 257371 |
| SANDOZ AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2025-05-15 | 2025-11-18 | 257374 |
| SANDOZ AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2025-05-15 | 2025-11-18 | 257377 |
| SANDOZ AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | To be discontinued | 2025-05-15 | 2025-05-15 | 257384 |
| SANDOZ AMPHETAMINE XR | 15MG | CAPSULE (EXTENDED RELEASE) | To be discontinued | 2025-05-15 | 2025-05-15 | 257387 |
| SANDOZ CLOBETASOL | 0.05% | SPRAY | Discontinued | 2025-07-02 | 2025-07-03 | 261518 |
| SANDOZ CLOPIDOGREL | 75MG | TABLET | Discontinued | 2021-06-29 | 2021-06-29 | 141630 |
| SANDOZ CLOPIDOGREL | 75MG | TABLET | Reversed | 2021-06-29 | 2021-06-29 | 141634 |
| SANDOZ COLCHICINE | 0.6MG | TABLET | Discontinued | 2023-11-27 | 2023-11-28 | 211608 |
| SANDOZ D 10 000 | 10000UNIT | CAPSULE | Discontinued | 2024-05-01 | 2024-05-02 | 226738 |